STAT+: J&J wins approval for first-of-its-kind psoriasis pill

Johnson & Johnson won U.S. approval for a daily psoriasis pill that rivals the benefits of injectable medicines and could roil a multibillion-dollar market.
Source
Stat News
Opens original article in a new tab

